Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Lamia, Hassani"'
Autor:
Moïse Houssen, Philippe-Henri Secretan, Loup Nobilet, Kilian Jossot, Laura Guichard, Cédric Mwamba, David Ngy, Lamia Hassani, Audrey Solgadi, Marie Antignac, Bernard Do, Helga Junot, Hassane Sadou Yayé
Publikováno v:
Pharmaceutics, Vol 16, Iss 8, p 977 (2024)
Doravarine (DOR) is an antiviral drug with a marketed authorization for the management of occupational blood and body fluid exposure. The currently existing packaging, consisting of multiple unit bottles comprising 30 tablets, is not fully appropriat
Externí odkaz:
https://doaj.org/article/f9eb9dc8120d4505b41e25d28cecd492
Autor:
Lucia Parlati, Mehdi Sakka, Aurelia Retbi, Samir Bouam, Lamia Hassani, Jean-François Meritet, Pierre Rufat, Dominique Bonnefont-Rousselot, Rui Batista, Benoit Terris, Agnès Bellanger, Dominique Thabut, Aurore Vozy, Jean-Philippe Spano, Romain Coriat, François Goldwasser, Selim Aractingi, Philippe Sogni, Stanislas Pol, Vincent Mallet, Jérôme Alexandre, Jennifer Arrondeau, Pascaline Boudou-Rouquette, Sixtine De Percin, Nora Kramkimel, Olivier Huillard, Jeanne Chapron, Benedicte Deau-Fischer, Marie-Laure Brandely-Piat, Diane Damotte, Audrey Lupo, Marco Alifano, Marion Corouge, Clémence Hollande, Hélène Fontaine, Lorianne Lair Mehiri, Anaïs Vallet Pichard, Patrick Tilleul
Publikováno v:
JHEP Reports, Vol 5, Iss 12, Pp 100880- (2023)
Background & Aims: There is concern about the burden of liver injury in patients with cancer exposed to immune checkpoints inhibitors (ICIs). Methods: In a retrospective cohort study, we evaluated the likelihood of grade 3/4 liver injury, of grade 3/
Externí odkaz:
https://doaj.org/article/788878b251bf4c95a2f7143042e64143
Autor:
Maria Gloria Tarantini, Stéphanie Ramos, Philippe-Henri Secrétan, Laura Guichard, Lamia Hassani, Agnès Bellanger, Julien Mayaux, Patrick Tilleul, Fadwa El Kouari, Hassane Sadou Yayé
Publikováno v:
Pharmaceutics, Vol 14, Iss 3, p 550 (2022)
Background: The SARS-CoV-2 pandemic has resulted in a dramatic rise of the demand for medical devices and drugs. In this context, an important shortage of programmable syringe pumps, used to administrate different drugs in intensive care units, was s
Externí odkaz:
https://doaj.org/article/33708b8689b243ebbac5d3b8b35c2f99
Autor:
Lemya Mezdour, Tarek Mansoul, Riad Boussaid, Ahcene Bariout, Lamia Hassani, Amel Gherfi, Asma Bouhila, Ahmed Samaouel Chehad
Publikováno v:
Annales de Dermatologie et de Vénéréologie - FMC. 1:A165-A166
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb61fbb30665befc8eb119a7f4e45594
https://doi.org/10.1016/j.fander.2021.09.059
https://doi.org/10.1016/j.fander.2021.09.059
Autor:
Lemya Mezdour, Tarek Mansoul, Riad Boussaid, Ahcene Bariout, Lamia Hassani, Amel Gherfi, Asma Bouhila, Ahmed Samaouel Chehad
Publikováno v:
Annales de Dermatologie et de Vénéréologie - FMC. 1:A334
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d71e346059a0fd6bab3ef051742d328
https://doi.org/10.1016/j.fander.2021.09.396
https://doi.org/10.1016/j.fander.2021.09.396
Autor:
P. Tilleul, Martine Babiard, Najet Yagoubi, Philippe-Henri Secrétan, Hassane Sadou Yayé, A. Bellanger, Haroun Aouati, Ivo B. Rietveld, Bernard Do, Lamia Hassani
Publikováno v:
Journal of Pharmaceutical and Biomedical Analysis
Journal of Pharmaceutical and Biomedical Analysis, Elsevier, 2019, 178, pp.112896. ⟨10.1016/j.jpba.2019.112896⟩
Journal of Pharmaceutical and Biomedical Analysis, Elsevier, 2019, 178, pp.112896. ⟨10.1016/j.jpba.2019.112896⟩
The generic Mylan® etoposide (ETP) has been investigated as an alternative for Etopophos®, in part due to a global shortage of the latter. The generic alternative is different both in its formulation and in its very limited stability (6 h at 25 °C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f7bc7efee55e567a9682f8c525a7244
https://pubmed.ncbi.nlm.nih.gov/31600662
https://pubmed.ncbi.nlm.nih.gov/31600662
Autor:
Caroline Hochart, Lamia Hassani, A. Bellanger, S. Taillibert, Khe Hoang Xuan, Yasmine Hassani
Publikováno v:
Bulletin du Cancer. 99:513-520
In 2007, the use of a new therapeutic association that included two expensive drugs (bevacizumab and irinotecan), used in second line treatment for progressive glioblastoma, led to the increase of the monitoring and self-evaluation of the medical pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c92413d8244b730db20a6bb30da4644c
https://doi.org/10.1684/bdc.2012.1573
https://doi.org/10.1684/bdc.2012.1573
Autor:
Yasmine, Hassani, Caroline, Hochart, Lamia, Hassani, Sophie, Taillibert, Khe Hoang, Xuan, Agnès, Bellanger
Publikováno v:
Bulletin du cancer. 99(5)
In 2007, the use of a new therapeutic association that included two expensive drugs (bevacizumab and irinotecan), used in second line treatment for progressive glioblastoma, led to the increase of the monitoring and self-evaluation of the medical pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::18a2cf81d92172f529efcd1eeec5a0f7
https://pubmed.ncbi.nlm.nih.gov/22510224
https://pubmed.ncbi.nlm.nih.gov/22510224